MCCORMICK FRANK 4
4 · BridgeBio Pharma, Inc. · Filed Oct 31, 2025
Insider Transaction Report
Form 4
MCCORMICK FRANK
Director
Transactions
- Sale
Common Stock
2025-10-29$65.48/sh−111,755$7,317,315→ 766,583 total(indirect: By Trust) - Sale
Common Stock
2025-10-29$68.50/sh−8,598$588,985→ 723,372 total(indirect: By Trust) - Sale
Common Stock
2025-10-29$66.20/sh−31,116$2,059,749→ 735,467 total(indirect: By Trust) - Sale
Common Stock
2025-10-29$67.52/sh−3,497$236,130→ 731,970 total(indirect: By Trust) - Sale
Common Stock
2025-10-29$69.24/sh−43,393$3,004,349→ 679,979 total(indirect: By Trust)
Holdings
- 83,275
Common Stock
Footnotes (6)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 28, 2024.
- [F2]Represents the weighted average sale price of the shares sold from $65.00 to $65.999 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F3]Represents the weighted average sale price of the shares sold from $66.00 to $66.9875 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F4]Represents the weighted average sale price of the shares sold from $67.00 to $67.996 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F5]Represents the weighted average sale price of the shares sold from $68.005 to $68.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F6]Represents the weighted average sale price of the shares sold from $69.00 to $69.24 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.